A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 8, 2025

Primary Completion Date

May 31, 2028

Study Completion Date

December 31, 2030

Conditions

Desmoid TumorAggressive Fibromatosis

Interventions

DRUG

Nirogacestat oral tablet

Nirogacestat tablet

Trial Locations (2)

RECRUITING

Nagoya University Hospital, Nagoya

RECRUITING

National Cancer Center Hospital, Chuo Ku

All Listed Sponsors

lead

SpringWorks Therapeutics, Inc.

INDUSTRY

NCT07170644 - A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF) | Biotech Hunter | Biotech Hunter